Moderna Backs Off COVID Vaccine Patent In Dispute With NIH
Moderna announced on Friday that it has delayed pursuing a patent on its COVID-19 vaccine while it disputes the National Institutes of Health's contention that the agency's scientists should be added...To view the full article, register now.
Already a subscriber? Click here to view full article